3/1/2024  8:16:05 AM Chg. -0.020 Volume Bid9:58:00 PM Ask9:58:00 PM Market Capitalization Dividend Y. P/E Ratio
25.940EUR -0.08% 0
Turnover: 0.000
-Bid Size: - -Ask Size: - 14.56 bill.EUR 3.56% 10.59

Business description

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
 

Management board & Supervisory board

CEO
Michael Sen
Management board
Sara Hennicken, Dr. Ernst Wastler, Dr. Francesco De Meo, Sebastian Biedenkopf, Pierluigi Antonelli , Helen Giza
Supervisory board
Wolfgang Kirsch, Prof. Dr. D. Michael Albrecht, Stefanie Balling , Bernd Behlert , Michael Diekmann , Grit Genster , Konrad Kölbl , Frauke Lehmann , Prof. Dr. med. Iris Löw-Friedrich , Oscar Romero de Paco , Susanne Zeidler , Dr. Christoph Zindel
 

Company data

Name: Fresenius SE & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-608-0
Fax: -
E-mail: pr-fre@fresenius.com
Internet: www.fresenius.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 56.49%
IPO date: 12/18/1986

Investor relations

Name: Markus Georgi
IR phone: +49-6172-608-2485
IR Fax: +49-6172-608-2488
IR e-mail: ir-fre@fresenius.com

Main Shareholders

Institutional investors
 
61.00%
Else Kröner-Fresenius Stiftung
 
27.00%
Retail holdings
 
8.00%
Others
 
4.00%